Logo image
Plasma Biomarkers of Alzheimer's Disease in African Americans
Journal article   Open access   Peer reviewed

Plasma Biomarkers of Alzheimer's Disease in African Americans

Kaancan Deniz, Charlotte C. G. Ho, Kimberly G. Malphrus, Joseph S. Reddy, Thuy Nguyen, Troy P. Carnwath, Julia E. Crook, John A. Lucas, Neill R. Graff-Radford, Minerva M. Carrasquillo, …
Journal of Alzheimer's disease, Vol.79(1), pp.323-334
01/01/2021
DOI: 10.3233/JAD-200828
PMID: 33252078
url
https://doi.org/10.3233/JAD-200828View
Published (Version of record) Open Access

Abstract

Background/Objective: The aim of this study was to determine if plasma concentrations of 5 surrogate markers of Alzheimer's disease (AD) pathology and neuroinflammation are associated with disease status in African Americans. Methods: We evaluated 321 African Americans (159 AD, 162 controls) from the Florida Consortium for African-American Alzheimer's Disease Studies (FCA(3)DS). Five plasma proteins reflecting AD neuropathology or inflammation (A beta(42), tau, IL6, IL10, TNF alpha) were tested for associations with AD, age, sex, APOE and MAPT genotypes, and for pairwise correlations. Results: Plasma tau levels were higher in AD when adjusted for biological and technical covariates. APOE epsilon 4 was associated with lower plasma A beta(42) and tau levels. Older age was associated with higher plasma A beta(42), tau, and TNF alpha. Females had lower IL10 levels. Inflammatory proteins had strong pairwise correlations amongst themselves and with A beta(42). Conclusion: We identified effects of demographic and genetic variants on five potential plasma biomarkers in African Americans. Plasma inflammatory biomarkers and A beta(42) may reflect correlated pathologies and elevated plasma tau may be a biomarker of AD in this population.
Life Sciences & Biomedicine Neurosciences Neurosciences & Neurology Science & Technology

Details

Metrics

Logo image